The BfArM informs doctors and patients about the updated measures regarding the potential risk of SARS-CoV-2 transmission through the use of FMT. Due to the changed SARS-CoV-2 infection situation, the BfArM's guidelines on minimizing the risk of SARS-CoV-2 transmission through FMT from 01.04.2020 have been lifted. The collection of donor stool, production of FMT and treatment with FMT as part of clinical studies or as an individual treatment trial are possible.

To the risk information (full text available in German only)